COMPASS Pathways plc
$14.82+9.1%YTD+111.7%1Y+457.1%
Mentions · last 7 days
98
Price updated 17h ago·X counts updated 17h ago
What it does
Plain-English summary of the business — what they sell and how they make money.
Industry overviewAI analysisGenerated by AI from underlying data
Where Medical - Care Facilities sits in its cycle right now — and what that implies for $CMPS.
Medical - Care Facilities
Healthcare labor shortages remain structural — hospital systems continue to rely on travel nursing and locum physician staffing to fill permanent workforce gaps that training pipelines cannot replenish at the required rate. Value-based care Medicare Advantage population management is the parallel model shift gaining traction.
Top industry ETF
$IHFiShares U.S. Healthcare Providers ETF
+15.8%YTD
+16.7%1Y
Fundamentals & catalyst
Profitability, valuation, and the next earnings event — at a glance, with rule-of-thumb signals.
Key ratios
P/E
-6.9How much investors are paying per dollar of profit the company actually earned in the last 12 months. Lower means the stock looks cheaper relative to earnings.~15–25 is typical for the S&P 500; high-growth names trade 30+; hyper-growth or speculative can be 100+ or negative.ROIC
-44.0%What percentage return the business earns on every dollar of capital (equity + debt) deployed in operations. The cleanest measure of business quality.Above ~15% is high-quality; consistently above 25% suggests a real moat. Below the company's cost of capital is value-destroying.Op margin
0.0%Operating profit (after sales, marketing, R&D, and overhead but before interest and taxes) as a percentage of revenue. The clearest view of how well the underlying business is run.Mature business above 20% is healthy; software businesses can run 30%+; commodity / retail businesses operate in single digits.FCF yield
-11.2%Free cash flow (operating cash flow minus capex) divided by the company's market cap. The cash-on-cash return you'd get owning the whole business at today's price.Above ~5% is attractive; below ~2% means you're paying up for growth. Capital-light businesses (software) run higher than capital-heavy ones (utilities).P/S
0.0Same idea as P/E but per dollar of revenue. Useful for companies that aren't profitable yet, where P/E is meaningless.Under ~2 is cheap; software / SaaS often runs 8–15; well above 20 implies the market is pricing in very high future growth.ROE
-151%Net income as a percentage of shareholders' equity. Similar to ROIC but counts only the equity side.Above 20% is strong, but can be inflated by leverage — a heavily indebted company can show high ROE with weak underlying ROIC.Gross margin
0.0%Revenue minus the direct cost of producing what was sold, as a percentage of revenue. The first read on whether the product is structurally profitable.Software / SaaS is typically 70%+; consumer goods 30–50%; commodity / hardware businesses can be under 20%.D/E
0.0Total debt divided by shareholders' equity. Measures how much the business runs on borrowed money versus owner capital.Under 1 is conservative; 1–2 is typical for mature businesses; over 2 is leveraged and more sensitive to interest rates.Past earnings
QuarterReportedActualEstimateSurprise
Q1 2026May 13, 2026$-0.30$-0.45+33.3%
Q4 2025Mar 24, 2026$-0.59$-0.41-43.9%
Q3 2025Nov 4, 2025$-0.38$-0.40+5.0%
Q2 2025Jul 31, 2025$-0.38$-0.37-2.7%
Next earningsThu, Jul 30·consensus EPS $-0.39
Quarterly trend
QuarterRevenueYoYGrossOpEPSFCF
Q1 FY26$0———$0.70$-47.9M
Q4 FY25$0———$-1.00$-37.8M
Q3 FY25$0———$-1.44$-35.1M
Q2 FY25$0———$-0.41$-38.7M
Forward consensus
FYRevenueRangeEPSRangeAnalysts
FY26$2.3M$1.0M – $4.4M-$0.73-$0.91 – -$0.431
FY27$65.8M$11.8M – $152.1M-$1.39-$2.76 – -$0.789
FY28$226.6M$99.9M – $428.6M-$0.25-$0.54 – -$0.073
FY29$497.3M$219.2M – $940.8M$0.59$0.16 – $1.274
FY30$833.5M$367.4M – $1.6B$2.25$0.61 – $4.854
Setup & momentum
Volume, range, and moving-average position — the technical setup driving short-term moves.
Right now
Vol vs 30dToday's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.1.4×Today's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.
52w rangeWhere the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.99%Where the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.
vs 50d MALatest close vs the 50-day simple moving average. Positive = short-term trend is up.+36.5%Latest close vs the 50-day simple moving average. Positive = short-term trend is up.
vs 200d MALatest close vs the 200-day simple moving average. Positive = long-term trend is up.+100.3%Latest close vs the 200-day simple moving average. Positive = long-term trend is up.
Float & profile
FloatMid float · 101.5M shFree-float shares — the slice of issued stock actually available to trade. Lower buckets squeeze harder on a catalyst.Traded today5.4% of floatToday's volume as a percent of the free float. Above 5% on a single day is unusually high turnover for the available share count.β2.515-year weekly beta vs the S&P 500. Above 1.5 means the stock typically moves more than the index; below 0.8 moves less.
Insider activity
Recent open-market buys and sells by officers and directors — flagged when multiple insiders cluster.
Recent news
Latest headlines from major outlets, sourced and timestamped — context for whatever just moved.
A Breakthrough-Designated Depression Drug Is 86% Through Its Phase 3, With Topline Data Due This YearCompass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Compass Pathways Elects Kathleen Tregoning to Board of DirectorsCompass Pathways: A Trip Worth Taking Before The FDA VerdictCompass Pathways Eyes Q4 FDA Filing for Psilocybin Depression Drug After Phase 3 Wins
More in Medical - Care Facilities
Peers in the same group — one click to compare setups, fundamentals, and chatter.
Voices on X · top 3 · last 7 days